TrialTransplantation and cellular therapy2022

Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors.

Nosha Farhadfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.